Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.
about
Depression research: where are we now?The role of brain-derived neurotrophic factor in the pathophysiology of adolescent suicidal behaviorGetting the balance right: Established and emerging therapies for major depressive disordersThe neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampusBrain-derived neurotrophic factor: role in depression and suicideNeuropeptides in depression: role of VGFThe neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanismNeurobiology of depression: an integrated view of key findingsThe molecular neurobiology of depressionStress-Related Immune Markers in Depression: Implications for TreatmentA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesMolecular and genetic basis of depressionN-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidenceSex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor.Toward a biosignature for suicideNeurobiology of chronic mild stress: parallels to major depressionThe neurobiological bases of memory formation: from physiological conditions to psychopathologyAssociation between BDNF levels and suicidal behaviour: a systematic review and meta-analysis.Association between BDNF levels and suicidal behaviour: a systematic review protocolCaptodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonismRole of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in micePlasma BDNF levels vary in relation to body weight in femalesVagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brainGenome-Wide Identification of Basic Helix-Loop-Helix and NF-1 Motifs Underlying GR Binding Sites in Male Rat Hippocampus.Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Functional interactions between steroid hormones and neurotrophin BDNFKnockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis.Peripheral BDNF produces antidepressant-like effects in cellular and behavioral modelsAlterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine.Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer.Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation.Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.Serum Brain-Derived Neurotrophic Factors in Taiwanese Patients with Drug-Naïve First-Episode Major Depressive Disorder: Effects of Antidepressants.Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase.Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disordersDecrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: A systematic review and meta-analysis.Dietary fat intake and the risk of depression: the SUN Project.Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide sPlasma BDNF concentration, Val66Met genetic variant and depression-related personality traits.Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.
P2860
Q21198902-C40941FC-85E4-4562-B289-E739FF7DF7C7Q22306030-FFFDCD14-02E3-4D83-B814-3256EC522534Q24610225-C7F7857A-F79D-4241-9224-595848B89E29Q24615884-D7CA1E1C-0FB8-43FB-BEDB-C3A17C5A1145Q24647110-C8ECE2AE-9A90-4262-9E7E-ACADC2F0F9B6Q24647788-C1E779E5-401F-4CC2-8CFF-8798E284FB87Q24649251-CF1497FF-4151-434D-B330-ACF4A22B1752Q24655216-A22B390A-3867-400E-B337-53DCB4CD7475Q24656261-EA4A7E93-D568-48E3-8884-738C050B8C61Q26771607-7AE12652-9D0C-4AF6-BF38-1A66CDD58A24Q26786354-74A643A5-A649-472F-A76F-6ED658F69CDDQ26827615-99BF99DE-8E77-4168-8196-7C16468B4D43Q26849307-F09F4767-C071-4447-9751-722AF22D3ECEQ26866575-F9B2D2E4-CC63-456C-A302-E1012B301918Q27024934-E56EB5C4-47E1-4E67-8F87-5E3C677E5A95Q27026698-B4A25C3E-80A0-47A0-BC7F-9A4DCFAB5BD1Q27027770-83E4B344-16CE-4666-979A-956722011B44Q27320488-AE7E31C6-0F0C-42B3-929F-04A69F776FC9Q28082179-C78B2767-EAFB-44FD-AB41-1C45261862F3Q28294674-E9EFE55F-F5AB-4FB0-A1D0-94E1C24BB09DQ28385414-B96AC8F3-E5E0-4FDE-8530-F85FE5E610EEQ28727632-8B859523-E48D-40AC-992E-847AB68D322DQ28730177-44658889-BAE7-4E60-A768-00B0E52EDF0BQ30274762-0EA91EBF-364A-4920-AC1A-649B55DA1CE5Q30416883-D0A38D12-BB0A-4E62-88BC-D0C2A0BE9B4CQ30475604-65792C20-59D6-42AF-B6FD-4BA816D8FD4DQ30493524-14DD9F4E-08C7-43F5-AC4F-585519F26532Q30497021-E9623A8C-319A-4502-9E04-1F5F67D12750Q30855337-D51127D3-3D30-441E-82A6-7DD3266ACBA4Q33262485-CB156018-C415-4C3A-BB5E-C36A9F760037Q33434423-FA3EA52A-5A64-4D0C-8F5E-639BEF31AA61Q33442474-6FB36E2C-0449-4208-8F7F-E1FC59B91685Q33614189-D7211295-165B-40DB-880E-A73FF3A5B1A0Q33643252-4719F687-0765-467A-A586-20210920382EQ33672712-2618AA73-B183-4DD8-8CCB-5253AFD9B8D1Q33810104-2CA83ACD-E510-41D3-AF23-565FBD5A1ACBQ33813627-F64120F4-A52F-4BC4-85A7-3F82BBEC46A4Q33843600-C968600B-03BB-49F2-B60F-22AF1DB014E0Q34009120-58E15BDC-AF84-44F9-B7DF-CB547DD5A700Q34026112-CA01E465-604E-45A9-9AC6-0125BA904D5C
P2860
Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@en
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@nl
type
label
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@en
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@nl
prefLabel
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@en
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@nl
P2093
P1476
Neurotrophin levels in postmor ...... gnosis and psychotropic drugs.
@en
P2093
Félicien Karege
Geneviève Vaudan
Michèle Schwald
Nader Perroud
Romano La Harpe
P356
10.1016/J.MOLBRAINRES.2004.12.020
P577
2005-03-05T00:00:00Z